Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is used to relieve pain and inflammation in musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain episodes.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is indicated for inflammatory and degenerative joint diseases where it reduces pain and swelling.

- Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: decreases inflammation and slows disease progression. - Ankylosing spondylitis: reduces spinal stiffness and discomfort. - Acute pain: provides short‑term relief of moderate to severe pain.

Meloxicam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness often accompanied by an urge to vomit. - Diarrhea: loose, frequent stools. - Headache: mild to moderate pain in the head. - Dizziness: sensation of light‑headedness or unsteadiness. - Edema: mild swelling of the lower extremities.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: severe stomach or intestinal lesions. - Cardiovascular events: increased risk of heart attack or stroke. - Liver injury: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: reduced kidney function or acute kidney injury. - Anaphylaxis: life‑threatening allergic reaction.

Before prescribing meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess renal function: check baseline kidney parameters and adjust use in renal impairment. - Monitor hepatic status: perform liver function tests periodically. - Evaluate cardiovascular risk: avoid in patients with recent myocardial infarction or uncontrolled hypertension. - Use caution in elderly: increased susceptibility to gastrointestinal bleeding. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: increased lithium serum concentrations.

Moderate Interactions (Monitor Closely):\n- Methotrexate: potential for enhanced toxicity, especially at high doses. - ACE inhibitors or ARBs: may reduce renal perfusion, requiring monitoring of kidney function. - SSRIs or SNRIs: increased risk of gastrointestinal bleeding.